GLP Watchdog

Gala vs Sprout Health

Sprout Health has an open FDA warning letter dated September 9, 2025. Gala has none. On compounded tirzepatide injection, Gala costs $439 less a year at standing rates: $179 a month against $199 a month (billed every 4 weeks) at Sprout Health. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Sprout Health

Gala logo

Gala

8.5/10

Sprout Health logo

Sprout Health

8.0/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$149/moCompounded semaglutide injection, billed every 4 weeks
States
All 50 states
44 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Gala
Visit Sprout Health

Both Gala and Sprout Health are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, Sprout Health 8.0). How we are paid

What the record shows

  1. 01

    Sprout Health has an open FDA warning letter dated September 9, 2025. Gala has none.

  2. 02

    Sprout Health names two pharmacies, all 503A. Gala names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Gala costs $439 less a year at standing rates: $179 a month against $199 a month (billed every 4 weeks) at Sprout Health. It is one of two products the two sell at comparable terms.

  4. 04

    Only Gala lists a price for brand-name semaglutide pen.

  5. 05

    Gala covers six states Sprout Health does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Sprout Health

Compounded semaglutide injection

$179/mo

$2,148 a year

$149/moLower

$1,937 a year, 13 charges

Compounded tirzepatide injection

$179/moLower

$2,148 a year

$199/mo

$2,587 a year, 13 charges

Brand-name semaglutide pen

$1,299/mo

$15,588 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None on 4-week plans; the 12-month plan is paid up front
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
Full refund before the prescription is sent to the pharmacy; none after
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Gala: October 17, 2026. Sprout Health: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
  • No FDA warning letter on record
  • $439 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen, which Sprout Health does not price
  • Lists 50 states against 44
  • Names no compounding pharmacy
Visit Gala

The case for Sprout Health

8.0/10
  • $211 a year less on compounded semaglutide injection
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
Visit Sprout Health

Scores

Gala 8.5 · Sprout Health 8.0 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
7.2

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.0

Accessibility10%

10.0A
vs
B
9.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Sprout Health: questions

Sprout Health has an open FDA warning letter dated September 9, 2025. Gala has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Sprout Health names two pharmacies, all 503A. Gala names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Sprout Health, by $211 a year at standing rates. Gala: $179 a month, about $2,148 a year. Sprout Health: $149 a month (billed every 4 weeks), about $1,937 a year.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Sprout Health states you can cancel at any time; refunds: full refund before the prescription is sent to the pharmacy; none after.
Both Gala and Sprout Health are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, Sprout Health 8.0).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks